| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Departments of 1 Physiology and Biophysics and 2 Nutrition, Case Western Reserve University, Cleveland, Ohio 44106-4970; and 3 Department of Nutrition, University of Montreal, Montreal, Quebec H3C 3Y7, Canada
In the well-perfused heart, pyruvate carboxylation accounts for 3-6% of the citric acid cycle (CAC) flux, and CAC carbon is lost via citrate release. We investigated the effects of an acute reduction in coronary flow on these processes and on the tissue content of CAC intermediates. Measurements were made in an open-chest anesthetized swine model. Left anterior descending coronary artery blood flow was controlled by a extracorporeal perfusion circuit, and flow was decreased by 40% for 80 min to induce myocardial hibernation (n = 8). An intracoronary infusion of [U-13C3]lactate and [U-13C3]pyruvate was given to measure the entry of pyruvate into the CAC through pyruvate carboxylation from the 13C-labeled isotopomers of CAC intermediates. Compared with normal coronary flow, myocardial hibernation resulted in parallel decreases of 65% and 79% in pyruvate carboxylation and net citrate release by the myocardium, respectively, and maintenance of the CAC intermediate content. Elevation of the arterial pyruvate concentration by 1 mM had no effect. Thus a 40% decrease in coronary blood flow resulted in a concomitant decrease in pyruvate carboxylation and citrate release as well as maintenance of the CAC intermediates.
cardiac; citric acid cycle; dehydrogenase; metabolism; ischemia
This article has been cited by other articles:
|
|
 |
|
  A. K. Olson, O. M. Hyyti, G. A. Cohen, X.-H. Ning, M. Sadilek, N. Isern, and M. A. Portman Superior cardiac function via anaplerotic pyruvate in the immature swine heart after cardiopulmonary bypass and reperfusion Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2315 - H2320. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Mayr Metabolomics: Ready for the Prime Time? Circ Cardiovasc Genet, October 1, 2008; 1(1): 58 - 65. [Full Text] [PDF]
|
|
|
|
|
|
L. Zhou, H. Huang, T. A. McElfresh, D. A. Prosdocimo, and W. C. Stanley Impact of anaerobic glycolysis and oxidative substrate selection on contractile function and mechanical efficiency during moderate severity ischemia Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H939 - H945. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. C. Okere, T. A. McElfresh, D. Z. Brunengraber, W. Martini, J. P. Sterk, H. Huang, M. P. Chandler, H. Brunengraber, and W. C. Stanley Differential effects of heptanoate and hexanoate on myocardial citric acid cycle intermediates following ischemia-reperfusion J Appl Physiol, January 1, 2006; 100(1): 76 - 82. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Sabatine, E. Liu, D. A. Morrow, E. Heller, R. McCarroll, R. Wiegand, G. F. Berriz, F. P. Roth, and R. E. Gerszten Metabolomic Identification of Novel Biomarkers of Myocardial Ischemia Circulation, December 20, 2005; 112(25): 3868 - 3875. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. T. Mallet, J. Sun, E. M. Knott, A. B. Sharma, and A. H. Olivencia-Yurvati Metabolic Cardioprotection by Pyruvate: Recent Progress Experimental Biology and Medicine, July 1, 2005; 230(7): 435 - 443. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. C. Stanley, F. A. Recchia, and G. D. Lopaschuk Myocardial Substrate Metabolism in the Normal and Failing Heart Physiol Rev, July 1, 2005; 85(3): 1093 - 1129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zhou, J. E. Salem, G. M. Saidel, W. C. Stanley, and M. E. Cabrera Mechanistic model of cardiac energy metabolism predicts localization of glycolysis to cytosolic subdomain during ischemia Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2400 - H2411. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Sharma, I. C. Okere, D. Z. Brunengraber, T. A. McElfresh, K. L. King, J. P. Sterk, H. Huang, M. P. Chandler, and W. C. Stanley Regulation of pyruvate dehydrogenase activity and citric acid cycle intermediates during high cardiac power generation J. Physiol., January 15, 2005; 562(2): 593 - 603. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Khairallah, F. Labarthe, B. Bouchard, G. Danialou, B. J. Petrof, and C. Des Rosiers Profiling substrate fluxes in the isolated working mouse heart using 13C-labeled substrates: focusing on the origin and fate of pyruvate and citrate carbons Am J Physiol Heart Circ Physiol, April 1, 2004; 286(4): H1461 - H1470. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. C. Stanley Myocardial Energy Metabolism During Ischemia and the Mechanisms of Metabolic Therapies Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2004; 9(1_suppl): S31 - S45. [Abstract] [PDF]
|
|
|
|
|
|
G. Vincent, B. Bouchard, M. Khairallah, and C. Des Rosiers Differential modulation of citrate synthesis and release by fatty acids in perfused working rat hearts Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H257 - H266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Lloyd, C. Brocks, and J. C. Chatham Differential modulation of glucose, lactate, and pyruvate oxidation by insulin and dichloroacetate in the rat heart Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H163 - H172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Z. Martini, W. C. Stanley, H. Huang, C. D. Rosiers, C. L. Hoppel, and H. Brunengraber Quantitative assessment of anaplerosis from propionate in pig heart in vivo Am J Physiol Endocrinol Metab, February 1, 2003; 284(2): E351 - E356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Comte, G. Vincent, B. Bouchard, M. Benderdour, and C. Des Rosiers Reverse flux through cardiac NADP+-isocitrate dehydrogenase under normoxia and ischemia Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1505 - H1514. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
